Ketogenic Diet for Alzheimer's Disease
Also known as: Keto diet, LCHF, Metabolic therapy
Alzheimer's brain shows impaired glucose utilization. Ketones provide alternative fuel for energy-starved neurons.
Mechanism of Action
In Alzheimer's, glucose hypometabolism occurs early (visible on FDG-PET before symptoms). BHB bypasses the glucose utilization deficit, providing direct mitochondrial fuel. It also activates AMPK, promotes autophagy, reduces neuroinflammation through NLRP3 inflammasome suppression, and serves as an HDAC inhibitor supporting neuroprotective gene expression.
General mechanism: High-fat, very-low-carbohydrate diet inducing ketosis. BHB serves as alternative fuel, HDAC inhibitor, AMPK activator, anti-inflammatory agent.
Current Evidence
The BEAM trial showed cognitive improvement with modified Mediterranean-ketogenic diet in MCI/early AD. MCT oil supplementation (which generates ketones) showed cognitive benefit in APOE4-negative patients. Sustained ketosis is challenging for elderly patients.
Clinical Status: Phase II trials (BEAM). MCT oil studies positive for APOE4-negative patients. Feasibility studies ongoing.
Safety Profile
Generally safe with medical supervision. Kidney stone risk, lipid profile changes, nutritional deficiencies without supplementation. Contraindicated in fatty acid oxidation disorders.
Key Research Questions
- Can ketone ester supplements provide cognitive benefit without full dietary adherence?
- Does the ketogenic diet slow Alzheimer's progression as measured by amyloid/tau biomarkers?
- Why do APOE4 carriers respond differently to ketone-based interventions?
Frequently Asked Questions
Does the ketogenic diet help with cancer?
The ketogenic diet exploits the Warburg effect — cancer cells' dependence on glucose. Clinical trials in glioblastoma show safety and metabolic benefits as adjunctive therapy. It may enhance chemotherapy and radiation effectiveness. It's studied as complementary, not replacement, therapy.
Ketogenic diet for Alzheimer's prevention
Alzheimer's involves impaired brain glucose metabolism (sometimes called 'type 3 diabetes'). Ketones provide an alternative brain fuel. The modified Mediterranean-ketogenic diet (MMKD) trial showed improved CSF Alzheimer's biomarkers. Most promising for MCI and early-stage prevention.